WellPoint Taps IBM Watson For Cancer Decision Support - InformationWeek

InformationWeek is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them.Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

IoT
IoT
Healthcare // Clinical Information Systems
News
12/22/2011
12:49 PM
50%
50%

WellPoint Taps IBM Watson For Cancer Decision Support

Los Angeles cancer institute will also contribute to the project, which aims to use Watson-based technology to improve treatment outcomes.

5 Key Elements For Clinical Decision Support Systems
5 Key Elements For Clinical Decision Support Systems
(click image for larger view and for slideshow)
The Cedars-Sinai Samuel L. Oschin Comprehensive Cancer Institute in Los Angeles has agreed to help health insurer WellPoint develop clinical decision support tools for oncology based on the IBM Watson technology. The goal is to apply the latest evidence from the medical literature and clinical trials to individual cases so that physicians can make better-informed medical decisions at the point of care.

WellPoint and IBM announced in September that they would jointly create commercial decision support tools, using the Watson supercomputer's ability to understand language and analyze vast amounts of information in the blink of an eye.

Cedars-Sinai will help develop the clinical content in WellPoint's decision support applications for breast, colon, and lung cancer. The institute's experts will also evaluate and provide feedback on tests of the decision support tools, but the institute has no plans to use those solutions in patient care.

Dr. William Audeh, MD, medical director of the cancer institute, said in a press release that he viewed the effort as a way to provide oncologists--especially those outside of academic medical centers--with increased understanding of the evolving body of knowledge in cancer research. In an interview with eWeek, Audeh emphasized the importance of new developments in genomic medicine, and he said the hope is that Watson will help clinicians tailor treatments to individual patients.

[ See what else Watson is doing to improve healthcare. Read IBM, Georgia Tech Point Data Modeling At Kids Health. ]

The growing complexity of cancer diagnosis and treatment is a prime reason why WellPoint chose to address this disease first, said Andrew J. Lang, senior VP and chief information officer of WellPoint, in an interview with InformationWeek Healthcare.

"There's wide variability in cancer treatment and a lot of new developments are occurring there," he said. Watson could help physicians keep up with the latest evidence and select the best solutions for individual patients, he argued. And if useless or less effective treatments were avoided, it could lower the costs of treating this very expensive condition, he noted.

Clinical decision support tools of various kinds have been around for decades, but physicians have not used them very much. Why should Watson-based solutions be any different?

"Previous decision support tools were much more static and were very rules-based, and the rules had to be clearly mapped out and programmed," Lang replied. "They didn't allow for a learning-type engine because the technology wasn't there yet."

Watson, on the other hand, can process unstructured information and can learn from its mistakes, he noted. "This change in the use of technology puts us on a path that enables us to take in a lot of the unstructured information that surrounds the medical field and allows us to process that in a way that will be much more relevant to physicians."

Only a small portion of medical studies are relevant to a particular case. But with the help of clinical experts such as those at Cedars-Sinai, Lang said, "Watson can start to recognize which evidence it should give greater weight to and how it should apply that," based on patient records and other factors, including genomics.

Depending on the pace of development, WellPoint hopes to take its decision support tools to some oncology groups for field testing within the next year, Lang said. The company also plans to branch out to other conditions, including additional cancers, cardiovascular diseases, and other chronic ailments.

In the long run, WellPoint and IBM also want to apply Watson across the continuum of care, Lang added. This could involve intervening earlier in the process of treating a condition. "You could also use it to help with care coordination, to move further through your treatment protocols and make adjustments as new information comes in about how a patient is responding."

WellPoint has no current plans to use the Watson decision support tools in evaluating the performance of network providers, Lang said. "But clearly as the [Watson] engine gets more intelligent, and we're able to move to evidence-based decision information for physicians, naturally physicians are going to migrate to using the better information that's tied to the right evidence. And we'll want to have a continued dialog with our providers on how best to apply and use this solution."

When are emerging technologies ready for clinical use? In the new issue of InformationWeek Healthcare, find out how three promising innovations--personalized medicine, clinical analytics, and natural language processing--show the trade-offs. Download the issue now. (Free registration required.)

We welcome your comments on this topic on our social media channels, or [contact us directly] with questions about the site.
Comment  | 
Print  | 
More Insights
Comments
Newest First  |  Oldest First  |  Threaded View
Lisa Henderson
50%
50%
Lisa Henderson,
User Rank: Apprentice
1/6/2012 | 12:41:23 AM
re: WellPoint Taps IBM Watson For Cancer Decision Support
The concept of applying the evolving decision support capabilities of the Watson computer are intriguing when placed against a complex and evolving disease(s) as cancer. Hopefully, the gains in the continuum of care extend to increasing management or eradication of these targeted areas.

Lisa Henderson, InformationWeek Healthcare, contributing editor
Commentary
Why It's Nice to Know What Can Go Wrong with AI
James M. Connolly, Editorial Director, InformationWeek and Network Computing,  11/11/2019
Slideshows
Top-Paying U.S. Cities for Data Scientists and Data Analysts
Cynthia Harvey, Freelance Journalist, InformationWeek,  11/5/2019
Slideshows
10 Strategic Technology Trends for 2020
Jessica Davis, Senior Editor, Enterprise Apps,  11/1/2019
White Papers
Register for InformationWeek Newsletters
Video
Current Issue
Getting Started With Emerging Technologies
Looking to help your enterprise IT team ease the stress of putting new/emerging technologies such as AI, machine learning and IoT to work for their organizations? There are a few ways to get off on the right foot. In this report we share some expert advice on how to approach some of these seemingly daunting tech challenges.
Slideshows
Flash Poll